Taking a Gap Year: How to Structure It for Success Webinar

Medha is a medical student at the Perelman School of Medicine at the University of Pennsylvania. Her interests include working at the intersection of business and medicine, particularly in healthcare delivery innovation. Before medical school, she spent two years working in life sciences consulting at ClearView Healthcare Partners in Boston. At Perelman, she has worked with Penn Medicine/Wharton Fund for Health and Wharton Investment Venture Associates, co-founded an accelerator for social determinants of health startups through Penn HealthX, and conducted research at the Center for Surgery and Health Economics. Her other involvements include the Oncology Interest Group, South Asian Medical Student Association, and Unity Community Clinic. She also was an interviewer for admissions and afterwards served on the Committee of Admissions at Perelman. Medha is originally from Pittsburgh and also completed her undergrad at Penn, where she was a Biology major.At Inspira, Medha is eager to mentor and get to know applicants pursuing their passions in medicine!‍

Karthik earned an MS in Stem Cell Biology and a BS in Neuroscience with a minor in Health Care Studies from the University of Southern California. He is presently an MD candidate at the Yale University School of Medicine.During his undergrad, Karthik worked as a synaptic electrophysiology research assistant, an ambulance EMT, and a vice president for a student-run veteran’s rehabilitation organization. During his Master’s, Karthik explored the prospect of new stem-cell-based methods for use in antifibrotics and next-generation (CAR) cell therapy. While he worked as a lab assistant for kidney organoid research at USC, Karthik started and led his non-profit SROA to tackle stem cell treatment fraud. More recently, Karthik worked at City of Hope as a clinical genetics assistant, supporting genetic counseling and precision medicine for patients facing cancer. As a current medical student, Karthik is interested in clinical trial equity, cancer outcomes, immuno-oncology therapeutics, and the power of venture capital in advancing medicine.